GB2325463B - Attenuated polioviruses - Google Patents

Attenuated polioviruses

Info

Publication number
GB2325463B
GB2325463B GB9805810A GB9805810A GB2325463B GB 2325463 B GB2325463 B GB 2325463B GB 9805810 A GB9805810 A GB 9805810A GB 9805810 A GB9805810 A GB 9805810A GB 2325463 B GB2325463 B GB 2325463B
Authority
GB
United Kingdom
Prior art keywords
attenuated polioviruses
polioviruses
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9805810A
Other versions
GB2325463A (en
GB9805810D0 (en
Inventor
David Philip Minor
Andrew Joseph Macadam
Jeffrey William Almond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd, British Technology Group Ltd filed Critical BTG International Ltd
Publication of GB9805810D0 publication Critical patent/GB9805810D0/en
Publication of GB2325463A publication Critical patent/GB2325463A/en
Application granted granted Critical
Publication of GB2325463B publication Critical patent/GB2325463B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB9805810A 1997-03-19 1998-03-18 Attenuated polioviruses Expired - Fee Related GB2325463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9705669.1A GB9705669D0 (en) 1997-03-19 1997-03-19 Attenuated polioviruses

Publications (3)

Publication Number Publication Date
GB9805810D0 GB9805810D0 (en) 1998-05-13
GB2325463A GB2325463A (en) 1998-11-25
GB2325463B true GB2325463B (en) 1999-07-07

Family

ID=10809494

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9705669.1A Pending GB9705669D0 (en) 1997-03-19 1997-03-19 Attenuated polioviruses
GB9805810A Expired - Fee Related GB2325463B (en) 1997-03-19 1998-03-18 Attenuated polioviruses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9705669.1A Pending GB9705669D0 (en) 1997-03-19 1997-03-19 Attenuated polioviruses

Country Status (5)

Country Link
EP (1) EP0968278A1 (en)
JP (1) JP2001519655A (en)
CA (1) CA2283638A1 (en)
GB (2) GB9705669D0 (en)
WO (1) WO1998041619A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0615933D0 (en) * 2006-08-10 2006-09-20 Nat Inst Biological Standards & Control Attenuated polioviruses
EP4368202A3 (en) 2007-03-30 2024-08-21 The Research Foundation for The State University of New York Attenuated viruses useful for vaccines
GB201022077D0 (en) 2010-12-29 2011-02-02 Health Prot Agency Inactivated poliovaccine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383434A1 (en) * 1989-01-18 1990-08-22 Btg International Limited Attenuated viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121779T1 (en) * 1988-01-11 1995-05-15 American Cyanamid Co NON-REPEAT RNS VIRUSES.
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383434A1 (en) * 1989-01-18 1990-08-22 Btg International Limited Attenuated viruses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
UCLA Symp. Mol. Cell. Biol. Vol.54 1987 Nomoto A et.al. pages 437-452 *
Virology Vol. 189 1992. Macadam A J et.al. pages 415-422 *
Virus Research Vol.21 1991. Muzychenko A R et. al. pages 111-122 *

Also Published As

Publication number Publication date
WO1998041619A1 (en) 1998-09-24
GB2325463A (en) 1998-11-25
JP2001519655A (en) 2001-10-23
GB9805810D0 (en) 1998-05-13
GB9705669D0 (en) 1997-05-07
EP0968278A1 (en) 2000-01-05
CA2283638A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
GB2309252B (en) Latch
EP1037635A4 (en) Compounds and methods
EP1102535A4 (en) Compounds and methods
IL136455A0 (en) Attenuated invasive bacteria
GB9705787D0 (en) Modified dendroaspins
NZ332102A (en) Meat decontamination
HUP0102707A3 (en) Attenuated pestiviruses
HK1042847A1 (en) Bone-pathobolism treating agent
GB2329126B (en) Disinfectant solutions
GB9701963D0 (en) Steriliser
GB2325463B (en) Attenuated polioviruses
ZA988492B (en) Substituted tetrahydro-naphthalenes and analogous compounds
GB9807503D0 (en) Use
EP0935965A4 (en) Antipylori agent
GB2310685B (en) Latch
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
GB9828550D0 (en) Treatment
AU1167P (en) Treat xTriticosecale
PL318517A1 (en) Disinfecting agent
GB9716742D0 (en) Treatment
GB9811555D0 (en) I/O unit
TW369823U (en) Latch
TW329817U (en) Lack latch
ZA982196B (en) Cercosporin-degrading bacteria

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020318